Search research articles
Contact Us
Filters
Showing results (301-310 of 471) with videos related to
Page
of 48
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
May 16, 2012
Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients
Stephen D Guy, Adrian R Tramontana, Leon J Worth, et al.
Journal of Pediatric Hematology/Oncology
|
August 22, 2015
Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma
Grace Kong, Michael S Hofman, William K Murray, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 4, 2015
High-resolution pulmonary ventilation and perfusion PET/CT allows for functionally adapted intensity modulated radiotherapy in lung cancer
Shankar Siva, Roshini Thomas, Jason Callahan, et al.
Leukemia & Lymphoma
|
April 25, 2007
Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure
Ashley P Ng, Andrew Wirth, John F Seymour, et al.
Melanoma Research
|
June 17, 2014
Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma
Samantha E Bowyer, Aparna D Rao, Megan Lyle, et al.
Molecular Pharmaceutics
|
February 14, 2017
Sulfonation of Tyrosine as a Method To Improve Biodistribution of Peptide-Based Radiotracers: Novel <sup>18</sup>F-Labeled Cyclic RGD Analogues
Mohammad B Haskali, Delphine Denoyer, Wayne Noonan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 10, 2016
BRAF Inhibition in BRAFV600E-Positive Anaplastic Thyroid Carcinoma
Annette M Lim, Graham R Taylor, Andrew Fellowes, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 6, 2011
Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer
David S Binns, Andrea Pirzkall, Wei Yu, et al.
Gynecologic Oncology
|
March 30, 2020
Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical care
Luke McLean, James R Whittle, Jonathan Graham, et al.
Plos One
|
November 25, 2015
Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy
Shu Wen Wen, Sarah J Everitt, Justin Bedő, et al.
Page
of 48
Search research articles
Search
Showing results (301-310 of 471) with videos related to
Sort By:
Page
of 48
European Journal of Nuclear Medicine and Molecular Imaging
|
May 16, 2012
Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients
Stephen D Guy, Adrian R Tramontana, Leon J Worth, et al.
Journal of Pediatric Hematology/Oncology
|
August 22, 2015
Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma
Grace Kong, Michael S Hofman, William K Murray, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 4, 2015
High-resolution pulmonary ventilation and perfusion PET/CT allows for functionally adapted intensity modulated radiotherapy in lung cancer
Shankar Siva, Roshini Thomas, Jason Callahan, et al.
Leukemia & Lymphoma
|
April 25, 2007
Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure
Ashley P Ng, Andrew Wirth, John F Seymour, et al.
Melanoma Research
|
June 17, 2014
Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma
Samantha E Bowyer, Aparna D Rao, Megan Lyle, et al.
Molecular Pharmaceutics
|
February 14, 2017
Sulfonation of Tyrosine as a Method To Improve Biodistribution of Peptide-Based Radiotracers: Novel <sup>18</sup>F-Labeled Cyclic RGD Analogues
Mohammad B Haskali, Delphine Denoyer, Wayne Noonan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 10, 2016
BRAF Inhibition in BRAFV600E-Positive Anaplastic Thyroid Carcinoma
Annette M Lim, Graham R Taylor, Andrew Fellowes, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 6, 2011
Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer
David S Binns, Andrea Pirzkall, Wei Yu, et al.
Gynecologic Oncology
|
March 30, 2020
Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical care
Luke McLean, James R Whittle, Jonathan Graham, et al.
Plos One
|
November 25, 2015
Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy
Shu Wen Wen, Sarah J Everitt, Justin Bedő, et al.
Page
of 48